Main Article Content

Abstract

A series of substituted curcumin analogues have been designed and synthesized via condensation reaction of benzaldehydes and dehydroacetic acid. Synthesized molecules were further evaluated for their inhibitory activity against various cancer cell lines. Most of the synthesized compounds were significantly inhibited the growth of these cell lines. Ten most active compounds in the series were further screened to check their inhibitory effect against filarial topoisomerase II enzyme. All the compounds screened against topoisomerase II exhibited excellent inhibition upto percentage inhibition more than 95 %. Further, the structure-activity relationships of the evaluated compounds reveals that among the synthesized compounds, nitro substituted chalcones 5 and 8 were the most active compounds having IC50 value of 5.49 and 4.46 μM against A549 (lung carcinoma) cell lines, respectively and significantly inhibited S. cervi Topoisomerase II activity upto more than 95 %.

Keywords

Curcumin Anticancer Topoisomerases II Chalcones

Article Details

How to Cite
Deepak Tripathi, V., & Kumar Shukla, A. (2018). Design and Synthesis of Novel Heterocyclic Curcumin Analogues as Anticancer Agents and Filarial Topoisomerase II Inhibitors. Asian Journal of Organic & Medicinal Chemistry, 3(4), 164–170. https://doi.org/10.14233/ajomc.2018.AJOMC-P149

References

  1. K. Nakagawa-Goto, T.-H. Chen, C.-Y. Peng, K.F. Bastow, J.-H. Wu and K.-H. Lee, Antitumor Agents 259. Design, Syntheses, and Structure-Activity Relationship Study of Desmosdumotin C Analogs, J. Med. Chem., 50, 3354 (2007); https://doi.org/10.1021/jm0702534.
  2. T. Hamaguchi, K. Ono and M. Yamada, REVIEW: Curcumin and Alzheimer's Disease, CNS Neurosci. Ther., 16, 285 (2010); https://doi.org/10.1111/j.1755-5949.2010.00147.x.
  3. L. Baum and A.J. Ng, Curcumin Interaction with Copper and Iron Suggests one Possible Mechanism of Action in Alzheimer's Disease Animal Models, Alzheimers Dis., 6, 367 (2004); https://doi.org/10.3233/JAD-2004-6403.
  4. S. Shishodia, M.M. Chaturvedi and B.B. Aggarwal, Role of Curcumin in Cancer Therapy, Curr. Probl. Cancer, 31, 243 (2007); https://doi.org/10.1016/j.currproblcancer.2007.04.001.
  5. S. Padhye, D. Chavan, S. Pandey, J. Deshpande, K.V. Swamy and F.H. Sarkar, Perspectives on Chemopreventive and Therapeutic Potential of Curcumin Analogs in Medicinal Chemistry, Mini Rev. Med. Chem., 10, 372 (2010); https://doi.org/10.2174/138955710791330891.
  6. R.A. Sharma, A.J. Gescher and W.P. Steward, Curcumin: The Story So Far, Eur. J. Cancer, 41, 1955 (2005); https://doi.org/10.1016/j.ejca.2005.05.009.
  7. A. Sharma, B. Chakravarti, M.P. Gupt, J. Siddiqui, R. Konwar and R.P. Tripathi, Synthesis and Anti Breast Cancer Activity of Biphenyl based Chalcones, Bioorg. Med. Chem., 18, 4711 (2010); https://doi.org/10.1016/j.bmc.2010.05.015.
  8. J.C. Aponte, M. Verástegui, E. Málaga, M. Zimic, M. Quiliano, A.J. Vaisberg, R.H. Gilman and G.B. Hammond, Synthesis, Cytotoxicity, and Anti-Trypanosoma cruzi Activity of New Chalcones, J. Med. Chem., 51, 6230 (2008); https://doi.org/10.1021/jm800812k.
  9. Z. Nowakowska, A Review of Anti-infective and Anti-inflammatory Chalcones, Eur. J. Med. Chem., 42, 125 (2007); https://doi.org/10.1016/j.ejmech.2006.09.019.
  10. M. Cabrera, M. Simoens, G. Falchi, M.L. Lavaggi, O.E. Piro, E.E. Castellano, A. Vidal, A. Azqueta, A. Monge, A.L. de Ceráin, G. Sagrera, G. Seoane, H. Cerecetto and M. González, Synthetic Chalcones, Flavanones and Flavones as Antitumoral Agents: Biological Evaluation and Structure-Activity Relationships, Bioorg. Med. Chem., 15, 3356 (2007); https://doi.org/10.1016/j.bmc.2007.03.031.
  11. L. Ni, C.Q. Meng and J.A. Sikorski, Recent Advances in Therapeutic Chalcones, Expert Opin. Ther. Pat., 14, 1669 (2004); https://doi.org/10.1517/13543776.14.12.1669.
  12. C.Q. Meng, X.S. Zheng, L. Ni, Z. Ye, J.E. Simpson, K.J. Worsencroft, M.R. Hotema, M.D. Weingarten, J.W. Skudlarek, J.M. Gilmore, L.K. Hoong, R.R. Hill, E.M. Marino, K.L. Suen, C. Kunsch, M.A. Wasserman and J.A. Sikorski, , Bioorg. Med. Chem. Lett., 14, 1513 (2004); https://doi.org/10.1016/j.bmcl.2004.01.021.
  13. B.K. Adams, E.M. Ferstl, M.C. Davis, M. Herold, S. Kurtkaya, R.F. Camalier, M.G. Hollingshead, G. Kaur, E.A. Sausville, F.R. Rickles, J.P. Snyder, D.C. Liotta and M. Shoji, Discovery of Novel Heteroaryl-Substituted Chalcones as Inhibitors of TNF-a-induced VCAM-1 Expression, Bioorg. Med. Chem., 12, 3871 (2004); https://doi.org/10.1016/j.bmc.2004.05.006.
  14. S.B. Katiyar, I. Bansal, J.K. Saxena and P.M.S. Chauhan, Syntheses of 2,4,6-Trisubstituted Pyrimidine Derivatives as a New Class of Antifilarial Topoisomerase II Inhibitors, Bioorg. Med. Chem. Lett., 15, 47 (2005); https://doi.org/10.1016/j.bmcl.2004.10.046.
  15. P. Wei, X. Zhang, S. Tu, S. Yan, H. Ying and P. Ouyang, New Potential Inhibitors of DNA Topoisomerase. Part II: Design and Synthesis of a-Lapachone Derivatives under Microwave Irradiation, Bioorg. Med. Chem. Lett., 19, 828 (2009); https://doi.org/10.1016/j.bmcl.2008.12.006.
  16. A. Kumar, S. Sharma, V.D. Tripathi, R.A. Maurya, S.P. Srivastava, G. Bhatia, A.K. Tamrakar and A.K. Srivastava, Design and Synthesis of 2,4-Disubstituted Polyhydroquinolines as Prospective Antihyperglycemic and Lipid Modulating Agents, Bioorg. Med. Chem., 18, 4138 (2010); https://doi.org/10.1016/j.bmc.2009.11.061.
  17. C. Zhao, J. Yang, Y. Wang, D. Liang, X. Yang, X. Li, J. Wu, X. Wu, S. Yang, X. Li and G. Liang, Synthesis of Mono-Carbonyl Analogues of Curcumin and Their Effects on Inhibition of Cytokine Release in LPS-Stimulated RAW 264.7 Macrophages, Bioorg. Med. Chem., 18, 2388 (2010); https://doi.org/10.1016/j.bmc.2010.03.001.
  18. Q. Zhang, Y. Zhong, L.-N. Yan, X. Sun, T. Gong and Z.-R. Zhang, Synthesis and Preliminary Evaluation of Curcumin Analogues as Cytotoxic Agents, Bioorg. Med. Chem. Lett., 21, 1010 (2011); https://doi.org/10.1016/j.bmcl.2010.12.020.
  19. S.-Y. Chen, Y. Chen, Y.-P. Li, S.-H. Chen, J.-H. Tan, T.-M. Ou, L.-Q. Gu and Z.-S. Huang, Design, Synthesis, and Biological Evaluation of Curcumin Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease, Bioorg. Med. Chem., 19, 5596 (2011); https://doi.org/10.1016/j.bmc.2011.07.033.